English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Myxedema coma is a rare yet commonly missed diagnosis. Early detection is key to management as this diagnosis carries a high mortality rate. We report a case of a 108-year-old female with a past medical history of CKD stage 3, hypertension, CHF, and atrial fibrillation who was brought to the emergency department (ED) by her grandson for seizures. The patient has no history of seizures, hypothyroidism (previous TSH 6 years back was 2.29 micro IU/mL), diabetes, or previous radiation exposure. The family noticed the first seizure 8 hours prior to admission with eyes rolling backward, shaking for 1 minute and slurred speech upon awakening. She had 2 other seizure episodes prior to arrival to the ED. Vitals in the ED showed a temperature of 31.7°C, BP of 85/50, HR of 35, RR of 8, and SpO2 was 83% on room air. Given the patient’s age, code status was changed to DNR/DNI. Blood work in the ED revealed a sodium of 146 mMol/L (136-145), anion gap of 25, Creatinine of 2.67 mg/dL (last creatinine prior to this admission was 1.65 mg/dL), and a troponin of 0.04 ng/mL (<0.04). Thyroid function testing was not done in the ED. Home medications included Lasix, digoxin, isosorbide mononitrate, and atenolol. The patient was admitted to the medical floor for workup of bradycardia and was being worked up for beta-blocker/digoxin toxicity but continued to be bradycardic despite atropine. She became hypoglycemic to 37 mg/dL. The patient was admitted to the CCU at night on day 1 of admission and was started on dopamine and glucagon drips. Sulfonylurea screen was negative, and the patient did not have further hypoglycemic episodes. While in the CCU, blood work showed a lactic acid of 10 mMol/L (0.4-2.0), TSH of 21.03 micro IU/mL (0.45-5.33), free T4 of 0.61 ng/dL (0.70-1.70), and total T3 71 ng/dL (87-178). Myxedema score was >130. Digoxin level came back elevated at 4.5 ng/ml (0.9-2.0). Cosyntropin stimulation testing was negative for adrenal insufficiency and thus the patient was not started on steroids. Urinalysis revealed pyuria with blood, but no urine cultures were done. Blood cultures were negative. The patient was given levothyroxine 200 mcg IV in the AM on Day 2 of admission and was started on antibiotics with azithromycin, cefepime, vancomycin, and metronidazole given concern for sepsis. Hypoglycemia resolved and glucagon was discontinued. In the evening of Day 2 of admission, despite being on a dopamine drip, the patient became increasingly bradycardic, hypotensive, and short of breath. She was initially stabilized after a dose of bicarb, atropine, and epinephrine. However, her BP and respiratory status continued to decline, and the patient passed away. In conclusion, myxedema coma should be suspected in patients presenting with typical symptoms and should be tested for on presentation even when no prior history of hypothyroidism exists.

SAT-507 Myxedema Coma: A Fatal Diagnosis in a Patient with No Known History of Hypothyroidism